Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke

被引：1
|
作者：
Kirshner, Howard S. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37232 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 33期
关键词：
Ischemic stroke; secondary stroke prevention; antiplatelet therapy; PERCUTANEOUS CORONARY INTERVENTION; ARTERIAL ORIGIN ESPRIT; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; CEREBRAL-ISCHEMIA; PLATELET-FUNCTION; CYP2C19; GENOTYPE; 1ST-EVER STROKE; BLOOD-PRESSURE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Stroke prevention is highly effective but underutilized in medical care. Lifestyle modification, in the form of diet, exercise, smoking cessation, antihypertensive therapy, close control of diabetes and hyperlipidemia, can prevent most strokes. Selected subgroups can benefit from carotid surgery or stenting, anticoagulation for atrial fibrillation, and antiplatelet therapy. Evidence for these approaches and alternative management strategies are discussed.
引用
收藏
页码：5261 / 5272
页数：12
相关论文
共 50 条
  • [31] Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
    Milionis, Haralampos
    Michel, Patrik
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3788 - 3794
  • [32] Mendelian Randomization Focused Analysis of Vitamin D on the Secondary Prevention of Ischemic Stroke
    Chan, Yap-Hang
    Schooling, C. Mary
    Zhao, Jie
    Yeung, Shiu-Lun Au
    Hai, Jo Jo
    Thomas, G. Neil
    Cheng, Kar-Keung
    Jiang, Chao-Qiang
    Wong, Yuen-Kwun
    Au, Ka-Wing
    Tang, Clara S.
    Cheung, Chloe Y. Y.
    Xu, Aimin
    Sham, Pak-Chung
    Lam, Tai-Hing
    Lam, Karen Siu-Ling
    Tse, Hung-Fat
    STROKE, 2021, 52 (12) : 3926 - 3937
  • [33] The Use of Antiplatelet Agents for Secondary Prevention of Ischemic Stroke in US Ambulatory Care Settings
    Niska, Richard
    Han, Beth
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2009, 20 (03) : 831 - 839
  • [34] Antiplatelet Treatment in Stroke: New Insights
    Milionis, Haralampos
    Liontos, Angelos
    Vemmos, Kostantinos
    Spengos, Konstantinos
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (29) : 4617 - 4626
  • [35] Patients Enrolled in Large Randomized Clinical Trials of Antiplatelet Treatment for Prevention After Transient Ischemic Attack or Ischemic Stroke Are Not Representative of Patients in Clinical Practice The Netherlands Stroke Survey
    Maasland, Lisette
    van Oostenbrugge, Robert J.
    Franke, Cees F.
    Reimer, Wilma J. M. Scholte op
    Koudstaal, Peter J.
    Dippel, Diederik W. J.
    STROKE, 2009, 40 (08) : 2662 - 2668
  • [36] New strategies for the prevention of stroke
    Liu, Ai-Jun
    Guo, Jin-Min
    Xia, Weiliang
    Su, Ding-Feng
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (02) : 265 - 271
  • [37] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Thomson, Ruth M.
    Anderson, David C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (02)
  • [38] Recommendation on the treatment of hypertension in the secondary prevention of ischemic stroke
    Sierra, C.
    Castilla-Guerra, L.
    Masjuan, J.
    Gil-Nunez, A.
    Alvarez-Sabin, J.
    Egocheaga, M., I
    Armario, P.
    HIPERTENSION Y RIESGO VASCULAR, 2018, 35 (04): : E11 - E18
  • [39] Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
    Anjum, Ibrar
    Kashif, Tooba
    Ahmed, Munis M.
    Sohail, Wafa
    Sarwar, Mohsin
    Khokhar, Imran
    CUREUS, 2018, 10 (06):
  • [40] Antiplatelet therapy in secondary stroke prevention
    Worrall B.B.
    Johnston K.C.
    Current Atherosclerosis Reports, 2000, 2 (2) : 104 - 109
12345